4th Jul 2018 12:48
LONDON (Alliance News) - Life sciences business OptiBiotix Health PLC has promoted its director of research & development to an executive board position.
Sofia Kolyda joins the board of OptiBiotix with immediate effect in her continued role as research & development director. She holds no other board positions nor has she held any appointments in the last five years.
Kolyda lead the company's development of SweetBiotix, a range of nutritional products such as high intensity sweeteners.
Shares in Optibiotix were down 0.8% at 67.15 pence on Wednesday.
Related Shares:
OptiBiotix Health